P1.005. Preliminary Pilot Study Cohort Results - Cost-Effective Surveillance Strategies and Prediction of Cancer Recurrence After Endoscopic Therapy for Barrett’s Esophagus (Endeavor)

Clicks: 21
ID: 325933
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #136 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Barrett‘s Esophagus: High-Grade Dysplasia and Early Invasive Cancer Background In many European countries, esophageal adenocarcinoma (EAC) incidence is increasing [1]. Barrett’s esophagus(BE), strongly associated with EAC, can progress via dysplasia to early and invasive adenocarcinoma [2]. Endoscopic treatment is the mainstay for early mucosal cancer (T1a/b) but requires intense post-treatment surveillance [3]. This results in overtreatment in most, and undertreatment in only a subset of patients [4]. The ENDEAVOR consortium, with over 10 partners from 8 European countries, will execute a 5-year project to develop a risk stratification model guiding treatment and surveillance. Below, preliminary results from the pilot study. Methods A total of 60 patients with BE and a visible lesion on endoscopy will be included in this study. Patients will be evaluated for endoscopic resection, with ablation therapy as needed. Forceps biopsies, brush biopsies and blood samples are taken before and after endoscopic resection. From these samples, clonal diversity measurements for HER-2, cMYC and CEP-17 are determined. Using these results, a determination of low or high clonal diversity is made. The degree of clonal diversity will be correlated to histopathological risk factors (lymphovascular invasion, differentiation grade, invasion depth) and recurrence events. Results Ongoing recruitment is at 33 patients. The population includes 6,1% female gender, mean age 67,27 (SD 10,42) and mean BMI 27,93 (SD 5,91). Median BE segment length is C1M3, 39,3% short-segment Barrett (<3cm maximum extent), and hernia diaphragmatica was present in 46,4% of patients. Paris classification lesion types consisted of Is (7; 20,59%), IIa (15; 44,12%), IIb (6; 17,65%), IIc (4; 11,76%). There were no Ip or III lesions included so far, 2 lesions (5,88%) were not classifiable. Of the 26 endoscopic resections performed so far, en bloc resection was performed in 23/26 procedures (88,46%). Histopathology staging has been obtained for 18 specimens, of which 9 were T0 (60%), 8 were T1a (33,33%) and 1 was T1b (6,67%) (see Table 1). In the 14 patients that have undergone endoscopy after endoscopic resection, There have been no recurrences registered so far, with average follow-up time after endoscopic resection of 3,54 months. Conclusion Our population includes an important number of patients with short-segment BE. With ongoing discussion about the surveillance intervals for short-segment BE, future data on recurrence rates in this subgroup will prove valuable. Continued follow-up to detect recurrences and biomarker analysis is being conducted.
Reference Key
openalex_W7203972194 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Martin Wyckmans, Rene Thieme, Rui Neves, Jennifer Kluczny, Henrik Maltzman, Fredrik Klevebro, Nikolas Stoecklein, Federica Ungaro, Alberto Barchi, Jacintha O'Sullivan, Dermot O'Toole, Jessie Elliott, Guillaume Piessen, Julien Branche, Veerle Coupé, Marjolein Greuter, Piotr Twardowski, Thomas Botelberge, Guido Van Hal, Costanza Di Patrizi, Nastaran Riahi Dehkordi, Dominiek De Wulf, Stefan Van Dongen, Ann Driessen, E Macken, S Bouhadan, Pieter Dewint, Sanne Hoefnagel, Michael Achiam, Laser Bazancir, David Tate, Magnus Nilsson, Sheila Krishnadath
Are you one of these authors? Claim your profile
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.153
URL
https://doi.org/10.1093/dote/doag077.153
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.